12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.

NCT00150254 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
625
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer